Breaking News Instant updates and real-time market news.

NEM

Newmont Goldcorp

$34.90

0.28 (0.81%)

, GG

Goldcorp

$11.12

0.25 (2.30%)

17:13
03/25/19
03/25
17:13
03/25/19
17:13

Paulson says no longer opposes Newmont Mining-Goldcorp merger, Bloomberg reports

Paulson & Co. told Bloomberg in an email that it no longer opposes Newmont's (NEM) proposed $10B merger with Goldcorp (GG) after Newmont announced a one-time special dividend. "Paulson & Co. commends the special dividend to Newmont shareholders," a spokesman said Monday by email. "Since the Newmont board and other significant shareholders are supportive of the revised terms, we will no longer oppose the transaction." In addition, Van Eck, which also previously voiced opposition to the deal, now says it plans to vote in favor of it, Danielle Bochove and Scott Deveau of Bloomberg report. Reference Link

NEM

Newmont Goldcorp

$34.90

0.28 (0.81%)

GG

Goldcorp

$11.12

0.25 (2.30%)

  • 11

    Apr

NEM Newmont Goldcorp
$34.90

0.28 (0.81%)

10/10/18
LEHM
10/10/18
INITIATION
Target $34
LEHM
Overweight
Newmont Mining initiated with an Overweight at Barclays
Barclays analyst Matthew Murphy started Newmont Mining with an Overweight rating and $34 price target. The analyst rolled out coverage on the North American mining sector with a positive outlook. The current dollar-positive macro dynamic has taken its toll on mining equities, offering investors an attractive entry point to the sector, Murphy tells investors in a research note.
01/15/19
CIBC
01/15/19
DOWNGRADE
CIBC
Neutral
Newmont Mining downgraded to Neutral from Outperformer at CIBC
01/15/19
ADAM
01/15/19
UPGRADE
ADAM
Buy
Newmont Mining upgraded to Buy from Hold at Canaccord
02/12/19
UBSW
02/12/19
DOWNGRADE
UBSW
Neutral
Goldcorp downgraded to Neutral from Buy at UBS
UBS analyst Cleve Reuckert downgraded Goldcorp (GG) to Neutral citing the pending takeover by Newmont Mining (NEM).
GG Goldcorp
$11.12

0.25 (2.30%)

01/07/19
MACQ
01/07/19
DOWNGRADE
MACQ
Neutral
Goldcorp downgraded to Neutral from Outperform at Macquarie
01/09/19
VERT
01/09/19
DOWNGRADE
VERT
Hold
Goldcorp downgraded to Hold from Buy at Vertical Research
02/26/19
RBCM
02/26/19
DOWNGRADE
RBCM
Sector Perform
Goldcorp downgraded to Sector Perform from Outperform at RBC Capital

TODAY'S FREE FLY STORIES

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

07:32
12/06/19
12/06
07:32
12/06/19
07:32
Hot Stocks
Biohaven's troriluzole successfully advances past interim futility analysis »

Biohaven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:30
12/06/19
12/06
07:30
12/06/19
07:30
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRIS

Curis

$1.86

0.045 (2.48%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Hot Stocks
Curis provides updated results from Phase 1 dose escalation study of CA-4948 »

Curis announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

XNCR

Xencor

$40.63

0.05 (0.12%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Conference/Events
Xencor to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

MRVL

Marvell

$23.44

-0.48 (-2.01%)

07:27
12/06/19
12/06
07:27
12/06/19
07:27
Recommendations
Marvell analyst commentary  »

Marvell price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

SON

Sonoco

$59.91

-0.04 (-0.07%)

07:25
12/06/19
12/06
07:25
12/06/19
07:25
Conference/Events
Sonoco to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 13

    Dec

RRC

Range Resources

$3.59

0.01 (0.28%)

07:23
12/06/19
12/06
07:23
12/06/19
07:23
Downgrade
Range Resources rating change  »

Range Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MR

Montage Resources

$5.30

0.09 (1.73%)

07:22
12/06/19
12/06
07:22
12/06/19
07:22
Upgrade
Montage Resources rating change  »

Montage Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TGTX

TG Therapeutics

$7.68

-0.51 (-6.23%)

07:19
12/06/19
12/06
07:19
12/06/19
07:19
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:15
12/06/19
12/06
07:15
12/06/19
07:15
Downgrade
Sage Therapeutics rating change  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$8.36

-0.42 (-4.78%)

07:15
12/06/19
12/06
07:15
12/06/19
07:15
Conference/Events
Aquestive Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

PHG

Philips

07:13
12/06/19
12/06
07:13
12/06/19
07:13
Upgrade
Philips rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$119.18

-2.64 (-2.17%)

07:13
12/06/19
12/06
07:13
12/06/19
07:13
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:10
12/06/19
12/06
07:10
12/06/19
07:10
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNST

Constellation Pharmaceuticals

$42.66

-3.34 (-7.26%)

07:08
12/06/19
12/06
07:08
12/06/19
07:08
Conference/Events
Constellation Pharmaceuticals to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

PBYI

Puma Biotechnology

$7.43

-1.52 (-16.98%)

07:07
12/06/19
12/06
07:07
12/06/19
07:07
Initiation
Puma Biotechnology initiated  »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.94

0.17 (0.54%)

07:06
12/06/19
12/06
07:06
12/06/19
07:06
Initiation
MGM Resorts initiated  »

MGM Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$119.18

-2.64 (-2.17%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Recommendations
Okta analyst commentary  »

Okta traction in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

RCKT

Rocket Pharmaceuticals

$19.76

0.54 (2.81%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Hot Stocks
Rocket Pharmaceuticals announces first patient treated in Phase 2 RP-L102 study »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

UCBJY

UCB

$0.00

(0.00%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Hot Stocks
UCB: Phase 3 BE SURE results met co-primary, ranked secondary endpoints »

UCB announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLG

SL Green Realty

$85.75

-0.08 (-0.09%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Conference/Events
SL Green Realty to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TELA

Tela Bio

$12.11

-1.09 (-8.26%)

07:04
12/06/19
12/06
07:04
12/06/19
07:04
Hot Stocks
Tela Bio awarded contract with HealthTrust Purchasing Group »

TELA Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

07:03
12/06/19
12/06
07:03
12/06/19
07:03
Recommendations
Ulta Beauty analyst commentary  »

Ulta Beauty results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

APLT

Applied Therapeutics

$21.78

-2.56 (-10.52%)

07:02
12/06/19
12/06
07:02
12/06/19
07:02
Hot Stocks
Applied Therapeutics to present pre-clinical data highlighting AT-001 »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$0.81

-0.0175 (-2.10%)

07:02
12/06/19
12/06
07:02
12/06/19
07:02
Hot Stocks
McDermott, Chiyoda, Zachry Group announce first liquid from Freeport LNG Train 2 »

McDermott with its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.